The chemopreventive agent oltipraz stimulates repair of damaged DNA

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1050-1053

  O'Dwyer, Peter J ^a,b,c   Johnson, Steven W ^a   Khater, Christina ^a   Krueger, Ann ^a   Matsumoto, Yoshihiro ^a   Hamilton, Thomas C ^a   Yao, Kang Shen ^a,b  

^a FOX CHASE CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CISPLATIN; OLTIPRAZ;

ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; CISPLATIN; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; HUMANS; PYRAZINES; TUMOR CELLS, CULTURED;

EID: 0030889233     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Graham, S., Dayal, H., Swanson, M., Mittelman, A., and Wilkinson, G. Diet in the epidemiology of cancer of the colon and rectum. J. Natl. Cancer Inst., 61: 709-714, 1978.
2. Haenszel, W., Locke, F. B., and Segi, M. A case-control study of large bowel cancer in Japan. J. Natl. Cancer Inst., 64: 17-22, 1980.
3. Rune, S., Kune, G. A., and Watson, L. F. Case-control study of dietary etiological factors: the Melbourne colorectal cancer study. Nutr. Cancer, 9: 21-42, 1987.
4. National Research Council. Inhibitors of carcinogenesis. In: Diet, Nutrition and Cancer, pp. 358-370. Washington, DC: National Academy Press, 1982.
5. Wattenberg, L. W., and Bueding, E. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis (Lond.), 7: 1379-1381, 1986.
6. Kensler, T. W., Egner, P. A., Dolan, P. M., Groopman, J. D., and Roebuck, B. D. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(pyrazinyl)- 4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Cancer Res., 47: 4271-4277, 1987.
7. Davidson, N. E., Egner, P. A., and Kensler, T. W. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) in rat liver. Cancer Res., 50: 2251-2255, 1990.
8. O'Dwyer, P. J., Szarka, C. E., Yao, K-S., Halbherr, T. C., Pfeiffer, G. R., Green, F., Gallo, J. M., Brennan, J., Frucht, H., Goosenberg, E. B., Hamilton, T. C., Litwin, S., Balshem, A. M., Engstrom, P. F., and Clapper, M. L. Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. J. Clin. Invest., 98: 1210-1217, 1996.
9. Rao, C. V., Tokoma, K., Kelloff, G., and Reddy, B. S. Inhibition by dietary oltipraz of experimental carcinogenesis induced by azoxymethane in male F344 rats. Carcinogenesis (Lond.), 12: 1051-1055, 1991.
10. 1-induced hepato-carcinogenesis by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Cancer Res., 51: 5501-5506, 1991.
11. Moon, R. C., Kelloff, G. J., Detrisac, C. J., Steele, V. E., Thomas, C. F., and Sigman, C. C. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz alone and in combination with 4-HPR and DFMO. Anticancer Res., 14: 5-12, 1994.
12. Clapper, M. L., Wood, M., Leahy, K., Lang, D., Miknyoczki, S., and Ruggeri, B. A. Chemopreventive activity of oltipraz against N-nitrosobis (2-oxopropyl) amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamsters. Carcinogenesis (Lond.), 16: 2159-2165, 1995.
13. Rao, C. V., Rivenson, A., Katiwalla, M., Kelloff, G. J., and Reddy, B. S. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Cancer Res., 55: 2502-2506, 1993.
14. Sancar, A. Excision repair in mammalian cells. J. Biol. Chem., 270: 15915-15918, 1995.
15. Matsumoto, Y., Kim, K,. and Bogenhagen, D. F. Proliferating cell nuclear antigen-dependent abasic site repair in Xenopus laevis oocytes: an alternative pathway of base excision DNA repair. Mol. Cell. Biol., 14: 6187-6197, 1994.
16. Tanaka, M., Lai, J-S., and Herr, W. Promoter-selective activation domains in oct-1 and oct-2 direct differential activation of an snRNA and mRNA promoter. Cell, 68: 755-767, 1992.
17. Johnson, S. W., Perez, R. P., Godwin, A. K., Yeung, A. T., Handel, L. M., Ozols, R. F., and Hamilton, T. C. Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines. Biochem. Pharmacol., 47: 689-697, 1994.
18. Jones, J. C., Zhen, W. P., Reed, E., Parker, R. J., Sancar, A., and Bohr, V. A. Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. J. Biol. Chem., 266: 7101-7107, 1991.
19. Yao, K-S., and O'Dwyer, P. J. Involvement of NF-κB in the induction of NAD(P)H: quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol., 1994.
20. Friedberg, E. C. DNA Repair, pp. 1-614. New York, NY: W. H. Freeman & Co, 1985.
21. Wallace, S. S. DNA damages processed by base-excision repair: biological consequences. Int. J. Radiat. Biol., 5: 579-589, 1994.
22. Frosina, G., Fortini, P., Rossi, O., Carrozzino, F., Raspaglio, G., Cox, L. S., Lane, D. P., Abbondandolo, A., and Dogliotti, E. Two pathways for base excision repair in mammalian cells. J. Biol. Chem., 271: 9573-9578, 1996.
23. Eastman, A. The function, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther., 34: 155-166, 1987.
24. Lai, G-M., Ozols, R. F., Smyth, J. F., Young, R. F., and Hamilton, T. C. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem. Pharmacol., 37: 4597-4600, 1988.
25. Masuda, H., Tanaka, T., Matsuda, H., and Kusaba, I. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichlo-roplatinum (II). Cancer Res., 50: 1863-1866, 1990.
26. Parker, R. J., Eastman, A., Bostick-Burton, F., and Reed, E. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J. Clin. Invest., 87: 772-777, 1991.
27. Eastman, A., and Schulte, N. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum (II). Biochemistry, 27: 4730-4734, 1988.
28. Zhen, W., Link, C. J., Jr., O'Conner, P. M., Reed, E., Parker, R., Howell, S. B., and Bohr, V.A. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol. Cell. Biol., 12: 3689-3698, 1992.
29. Johnson, S. W., Swiggard, P. A., Handel, L. M., Brennan, J. M., Godwin, A. K., Ozols, R. F., and Hamilton, T. C. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res., 54: 5911-5916, 1994.
30. Aboussekhra, A., Biggerstaff, M., Shivji, J. K., Vilpo, J. A., Moncollin, V., Podurt, V. N., Protic, M., Hubscher, U., Egly, J. M., and Wood, R.D. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell, 80: 859-868, 1995.
31. Egner, P. A., Kensler, T. W., Prestera, T., Talalay, P., Libby, A. H., Jeyner, H. H., and Curphey, T. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones. Carcinogenesis (Lond.), 15: 177-181, 1994.